Target intelligence / Profile preview

Damaged Neural Tissue

Molecular classification
Other
01

Overview

"Damaged neural tissue" is a non-specific term referring to neural (nervous system) tissue that has suffered physical, chemical, or degenerative injury. This condition engages a complex, coordinated repair response involving many cell types (Schwann cells, macrophages, fibroblasts, glia), which clean debris, modulate inflammation, and promote regeneration. Because the term does not refer to a single molecule, protein, or receptor, but rather a pathological tissue state, it cannot be used as a canonical drug target. Drug and biologic interventions in this context aim at modulating pathways or cells within injured neural tissue (e.g., targeting Schwann cell activation, macrophage polarization, or axon growth inhibitory signals), but not the damaged tissue itself as a singular receptor or protein.

Other names
Damaged nervous tissueInjured nerve tissueNeural injuryNeural lesion
02

Mechanism of action

Neuroprotection (e.g., reducing oxidative stress, inhibiting apoptosis); Promotion of neuronal survival and axon regeneration; Immunomodulation (modulating post-injury inflammation); Inhibiting inhibitory signaling cascades (e.g., RhoA/ROCK pathway antagonists)

03

Biological functions

Response to injuryDegenerationWound repairInflammationRegeneration
04

Disease associations

Neurodegenerative diseaseTraumaPeripheral neuropathySpinal cord injuryOther nervous system pathologies
05

Safety considerations

Risk of aberrant regeneration (neuroma, neuropathic pain)Uncontrolled inflammation or immunosuppressionOff-target effects of neurotrophic or immunomodulatory drugs
06

Interacting drugs

minocycline

5 more in the full profile.

07

Biomarkers

upregulation of c-JunS100bspecific cytokinesglial fibrillary acidic protein (GFAP)neurofilament proteins

Beyond the preview

Go deeper on Damaged Neural Tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged Neural Tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call